e-learning
resources
Berlin 2001
Sunday 23.09.2001
Acute and chronic infections in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The balance of pro- and anti - inflammatory cytokines in
Chlamydia pneumoniae
infected cells as a marker of inflammatory activity in the pulmonary compartment
J. Rupp, H. Kothe, A. Müller, H. A. Katus, K. Dalhoff (Lübeck, Germany)
Source:
Annual Congress 2001 - Acute and chronic infections in COPD
Session:
Acute and chronic infections in COPD
Session type:
Oral Presentation
Number:
1048
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Rupp, H. Kothe, A. Müller, H. A. Katus, K. Dalhoff (Lübeck, Germany). The balance of pro- and anti - inflammatory cytokines in
Chlamydia pneumoniae
infected cells as a marker of inflammatory activity in the pulmonary compartment. Eur Respir J 2001; 16: Suppl. 31, 1048
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003
Different expression of pro- and antiinflammatory cytokines in
chlamydia pneumoniae
infected blood monocytes and alveolar macrophages from COPD patients and healthy volunteers
Source: Eur Respir J 2002; 20: Suppl. 38, 220s
Year: 2002
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue
Source: Eur Respir J 2012; 40: 1458-1467
Year: 2012
Chlamydia pneumoniae
persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in
chlamydia pneumoniae
-induced activation of pulmonary immune cells
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Endogenous mediators of resolution
Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts
Year: 2006
The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
Imbalanced secretion of IL-1β and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients
Source: Eur Respir J 2003; 22: 274-279
Year: 2003
Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature
Source: Eur Respir J 2004; 23: 506-510
Year: 2004
The
moraxella catarrhalis
induced inflammatory response of pulmonary epithelial cells is mediated by activation of EGFR
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Interactions between epithelial cells and neutrophils during pro-inflammatory conditions
Source: Annual Congress 2011 - Lung cell biology
Year: 2011
Associations between lipid mediators and cytokine production at different stages of MTB infection
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021
Differential gene expression and cytokine production from neutrophils in asthma phenotypes
Source: Eur Respir J 2010; 35: 522-531
Year: 2010
Immunological mechanisms in pleural disease
Source: Eur Respir J 2003; 21: 539-544
Year: 2003
Streptococcus pneumoniae augments inflammatory process in asthma model without changing Th2 profile
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Interferon-β augments eosinophil adhesion-inducing activity of endothelial cells
Source: Eur Respir J 2008; 32: 1540-1547
Year: 2008
Alveolar macrophages are a more important source of active IL-18 compared to dendritic or monocyte cells in the presence of the bacterial virulence factor SipB
Source: Eur Respir J 2002; 20: Suppl. 38, 213s
Year: 2002
Chemokines induced in human lung epithelial cells by inflammatory cytokines
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006
Pulmonary inflammatory cells strongly express IL-18 in asthma death cases
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept